445 related articles for article (PubMed ID: 33767133)
1. FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer.
Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Liu B
Cell Death Dis; 2021 Mar; 12(4):317. PubMed ID: 33767133
[TBL] [Abstract][Full Text] [Related]
2. The USP18-FBXO6 axis maintains the malignancy of ovarian cancer.
Li G; Shi W; Xu Y; Li K; Chen Z; Lv M; Lv J; Qiu T; Qian Q; Ji J; Liu W; Liu B; Zhao Y
Biochem Biophys Res Commun; 2022 Feb; 593():101-107. PubMed ID: 35063764
[TBL] [Abstract][Full Text] [Related]
3. FBXO6-Mediated Ubiquitination and Degradation of Ero1L Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis.
Chen X; Duan LH; Luo PC; Hu G; Yu X; Liu J; Lu H; Liu B
Cell Physiol Biochem; 2016; 39(6):2501-2508. PubMed ID: 27855403
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.
Liu B; Zheng Y; Wang TD; Xu HZ; Xia L; Zhang J; Wu YL; Chen GQ; Wang LS
J Proteome Res; 2012 Mar; 11(3):1773-81. PubMed ID: 22268729
[TBL] [Abstract][Full Text] [Related]
5. FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer.
Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Ji J; Liu W; Liu B
Cell Death Dis; 2021 Jul; 12(8):758. PubMed ID: 34333526
[TBL] [Abstract][Full Text] [Related]
6. SCF
Cai L; Liu L; Li L; Jia L
Cell Signal; 2020 Jan; 65():109440. PubMed ID: 31678254
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase.
Lualdi M; Pedrini E; Rea K; Monti L; Scaldaferri D; Gariboldi M; Camporeale A; Ghia P; Monti E; Tomassetti A; Acquati F; Taramelli R
Oncotarget; 2015 Apr; 6(10):7851-65. PubMed ID: 25797262
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of tumor suppressor gene ribonuclease T2 and gametogenetin binding protein 2 is associated with drug resistance in ovarian cancer.
Yin F; Liu L; Liu X; Li G; Zheng L; Li D; Wang Q; Zhang W; Li L
Oncol Rep; 2014 Jul; 32(1):362-72. PubMed ID: 24842157
[TBL] [Abstract][Full Text] [Related]
9. Musashi-2 binds with Fbxo6 to induce Rnaset2 ubiquitination and chemokine signaling pathway during vascular smooth muscle cell phenotypic switch in atherosclerosis.
Zhang T; Wu S; Xu R; Zhang S; Wang M; Li J
Cell Signal; 2023 Nov; 111():110869. PubMed ID: 37633478
[TBL] [Abstract][Full Text] [Related]
10. Noncanonical Role of FBXO6 in Regulating Antiviral Immunity.
Du X; Meng F; Peng D; Wang Z; Ouyang W; Han Y; Gu Y; Fan L; Wu F; Jiang X; Xu F; Qin FX
J Immunol; 2019 Aug; 203(4):1012-1020. PubMed ID: 31308089
[TBL] [Abstract][Full Text] [Related]
11. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
12. Fbxo6 confers drug-sensitization to cisplatin via inhibiting the activation of Chk1 in non-small cell lung cancer.
Cai L; Li J; Zhao J; Guo Y; Xie M; Zhang X; Wang L; Tian H; Li A; Li Q; Miao Y
FEBS Lett; 2019 Jul; 593(14):1827-1836. PubMed ID: 31140586
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase Skp1-cullin-F-box ligase (SCF) interact through multiple conformations.
Sandoval D; Hill S; Ziemba A; Lewis S; Kuhlman B; Kleiger G
J Biol Chem; 2015 Jan; 290(2):1106-18. PubMed ID: 25425648
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.
Ponyeam W; Hagen T
Cell Signal; 2012 Jan; 24(1):290-5. PubMed ID: 21946088
[TBL] [Abstract][Full Text] [Related]
16. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.
Wei J; Dong S; Yao K; Martinez MFYM; Fleisher PR; Zhao Y; Ma H; Zhao J
FASEB J; 2018 Aug; 32(8):4284-4292. PubMed ID: 29522376
[TBL] [Abstract][Full Text] [Related]
17. HSP90 promotes radioresistance of cervical cancer cells via reducing FBXO6-mediated CD147 polyubiquitination.
Song Q; Wen J; Li W; Xue J; Zhang Y; Liu H; Han J; Ning T; Lu Z
Cancer Sci; 2022 Apr; 113(4):1463-1474. PubMed ID: 35043518
[TBL] [Abstract][Full Text] [Related]
18. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin E3 ligase SCF(β-TRCP) regulates TRIB2 stability in liver cancer cells.
Qiao Y; Zhang Y; Wang J
Biochem Biophys Res Commun; 2013 Nov; 441(3):555-9. PubMed ID: 24211582
[TBL] [Abstract][Full Text] [Related]
20. Tumor and metastasis suppression by the human RNASET2 gene.
Acquati F; Possati L; Ferrante L; Campomenosi P; Talevi S; Bardelli S; Margiotta C; Russo A; Bortoletto E; Rocchetti R; Calza R; Cinquetti R; Monti L; Salis S; Barbanti-Brodano G; Taramelli R
Int J Oncol; 2005 May; 26(5):1159-68. PubMed ID: 15809705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
